Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Regarding Completion of Exercise of 2nd Series Stock Acquisition Rights Issued by Third-Party Allotment
Notice of Application for Marketing Approval and Launch of Emergency Contraceptive Pill “LESOERU72”
Notice Regarding Revision of Earnings Forecast
Notice Regarding Loss on Valuation of Securities for the First Quarter of the Fiscal Year ending September 2026
Fuji Pharma, Ordinary Profit Forecast for First Half Revised Upward by 49%, Highest in Four Terms, Full Year also Increased
Richter and Fuji strengthen strategic collaboration
Notice of Licensing and Settlement Regarding Aflibercept 2mg BS (Biosimilar)
Marketing Approval for new specification of Ustekinumab Biosimilar
Notice of Additional Approval for the indication of Nextstellis by OLIC (Thailand) Limited
Fuji Pharma, 18% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Dividend Raised by 1.5 Yen
Notice of Settlement and License Agreement Regarding Golimumab BS (Biosimilar)
Notice of Settlement Agreement Regarding Denosumab BS (Biosimilar)
Notice of Application for Additional Approval of indication of Nextstellis by OLIC (Thailand) Limited
Marketing Approval for Three Biosimilars
Fuji Pharma, Oct-Jun (Cumulative 3Q) Ordinary Profit Increases by 6%
Notice Concerning Completion Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause
Notice Concerning Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause
Fuji Pharma, Jan-Mar (2Q) Ordinary Profit Decreases by 63%
Fuji Pharma, Oct-Dec (1Q) Ordinary Profit Turns to Profit
Fuji Pharma Co.,Ltd., 5% Increase in Ordinary Profit, Record High for The First Time in Eight Years, Dividend to Rise by 3 yen